Similar Articles
131 Endoscopic ultrasound-guided fiducial marker placement for neoadjuvant chemoradiation therapy for resectable pancreatic cancer
132 Single-nucleotide polymorphisms based genetic risk score in the prediction of pancreatic cancer risk
133 Validation of American Joint Committee on Cancer 8th edition of TNM staging in resected distal pancreatic cancer
134 MiR-301a transcriptionally activated by HIF-2α promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer
135 Nanomaterials: Applications in the diagnosis and treatment of pancreatic cancer
136 FOLFIRINOX vs gemcitabine/nab-paclitaxel for treatment of metastatic pancreatic cancer: Single-center cohort study
137 Early pancreatic cancer in IgG4-related pancreatic mass: A case report
138 Long non-coding RNA HULC as a diagnostic and prognostic marker of pancreatic cancer
139 Oral chemotherapy for second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer
140 New era for pancreatic endoscopic ultrasound: From imaging to molecular pathology of pancreatic cancer
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA